Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Probuphine NDA resubmitted to FDA

Sep. 1, 2015

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Aug. 24, 2015

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

Aug. 17, 2015

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

July 21, 2015

GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis

July 8, 2015

NIDA tests AZD-8529 for smoking cessation

July 7, 2015

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

July 1, 2015

BARDA exercises additional contract funding for AEOL-10150

July 1, 2015

NIAAA initiates trial of Horizant for alcohol use disorder

June 29, 2015

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

June 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...